Study: Moderna, Merck vaccines could cut melanoma's recurrence by 44 percent
There could be light at the end of the tunnel for individuals battling melanoma cancer. CBS News reported that researchers conducted a study to develop a "potential skin cancer vaccine" from Merck and Moderna, and found some promising results.
According to Reuters, a combination of Moderna's experimental melanoma vaccine and Merck's immunotherapy Keytruda "cut the risk of skin cancer's recurrence or death by 44 percent compared with Keytruda alone in a mid-stage trial."
Moderna's trial shot uses the same mRNA vaccine technology that has played an integral role in the success of COVID-19 vaccines, and the combination with Keytruda "has the capacity to be a new paradigm in the treatment of cancer," Paul Burton, Moderna's chief medical officer said in an interview.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There were 157 melanoma patients involved in the ongoing clinical trial, and researchers noted side effects in 14.4 percent of the patients who received the drug-vaccine combo compared to 10 percent of people who were only administered Keytruda, writes Reuters.
CBS notes that the shares of both the pharmaceutical and biotech companies increased on Tuesday after researchers reported a positive outcome of the shots midway through the study.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kelsee Majette has worked as a social media editor at The Week since 2022. In 2019, she got her start in local television as a digital producer and fill-in weather reporter at NTV News. Kelsee also co-produced a lifestyle talk show while working in Nebraska and later transitioned to 13News Now as a digital content producer.
-
North Carolina Supreme Court risks undermining its legitimacy
Under the radar A contentious legal battle over whether to seat one of its own members threatens not only the future of the court's ideological balance, but its role in the public sphere
By Rafi Schwartz, The Week US Published
-
Codeword: January 14, 2025
The Week's daily codeword puzzle
By The Week Staff Published
-
Sudoku hard: January 14, 2025
The Week's daily hard sudoku puzzle
By The Week Staff Published
-
Mirror bacteria could pose major health risks
Under the Radar The experimental research could have dangerous impacts
By Devika Rao, The Week US Published
-
Are pig-organ transplants becoming a reality?
The Explainer US woman has gene-edited pig-kidney transplant, and scientists hope experimental surgery could save thousands of lives
By Abby Wilson Published
-
US won its war on 'murder hornets,' officials say
Speed Read The announcement comes five years after the hornets were first spotted in the US
By Peter Weber, The Week US Published
-
2024: the year of distrust in science
In the Spotlight Science and politics do not seem to mix
By Devika Rao, The Week US Published
-
Dark energy data suggest Einstein was right
Speed Read Albert Einstein's 1915 theory of general relativity has been proven correct, according to data collected by the Dark Energy Spectroscopic Instrument
By Peter Weber, The Week US Published
-
New DNA tests of Pompeii dead upend popular stories
Speed Read An analysis of skeletal remains reveals that some Mount Vesuvius victims have been wrongly identified
By Peter Weber, The Week US Published
-
How AI-generated images are threatening science
Under The Radar Publishers and specialists are struggling to keep up with the impact of new content
By Abby Wilson Published
-
NASA's Europa Clipper blasts off, seeking an ocean
Speed Read The ship is headed toward Jupiter on a yearslong journey
By Peter Weber, The Week US Published